VEGFA and cancer: VEGF-signalling pathway inhibitors (VSPI) and/or immune checkpoint inhibitors (ICI) now make up the first-line anti-cancer treatment for a range of cancers [2] and have transformed the outcomes of people with advanced renal cancer [3, 4].